Inventor
PAUTSCH ALEXANDER
DE29 patents
⚠️ This page may combine multiple inventors who share the name “PAUTSCH ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
14 patentsUSRE47636EOct 8, 2019
Substituted spirocycles
BOEHRINGER INGELHEIM INT18 citations94
US9879026B2Jan 30, 2018
Substituted spirocycles
BOEHRINGER INGELHEIM INT17 citations94
US10238633B2Mar 26, 2019
Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
BOEHRINGER INGELHEIM INT18 citations93
US9713606B2Jul 25, 2017
Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
BOEHRINGER INGELHEIM INT20 citations92
US7517995B2Apr 14, 2009
Thiazolyl-dihydro-cyclopentapyrazole
BOEHRINGER INGELHEIM INT10 citations83
US9440960B2Sep 13, 2016
Substituted oxetanes and their use as inhibitors of cathepsin C
BOEHRINGER INGELHEIM INT17 citations81
US9540373B2Jan 10, 2017
Substituted spirocycles
BOEHRINGER INGELHEIM INT4 citations73
US10640486B2May 5, 2020
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations71
US10399961B2Sep 3, 2019
Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
BOEHRINGER INGELHEIM INT4 citations71
US7691868B2Apr 6, 2010
Thiazolyl-dihydro-quinazoline
BOEHRINGER INGELHEIM INT3 citations61
US11691960B2Jul 4, 2023
2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament
BOEHRINGER INGELHEIM INT0 citations57
US10793522B2Oct 6, 2020
Sulfonamides as inhibitors of the uptake of extracellular citrate
BOEHRINGER INGELHEIM INT0 citations47
US8357689B2Jan 22, 2013
Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
BOEHRINGER INGELHEIM INT0 citations40
US8354418B2Jan 15, 2013
Thiazolyl-dihydro-quinazolines
BOEHRINGER INGELHEIM INT0 citations40
ANDERSKEWITZ RALF
4 patentsUS8987249B2Mar 24, 2015
Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C
ANDERSKEWITZ RALF48 citations97
US9073869B2Jul 7, 2015
Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
ANDERSKEWITZ RALF20 citations92
US8877775B2Nov 4, 2014
Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
ANDERSKEWITZ RALF21 citations92
US8871783B2Oct 28, 2014
Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (cyano-methyl)-amides inhibitors of cathepsin C
ANDERSKEWITZ RALF18 citations83
BOEHRINGER INGELHEIM PHARMA
2 patentsWAGNER HOLGER
2 patentsUS8211923B2Jul 3, 2012
Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
WAGNER HOLGER51 citations92
US8232312B2Jul 31, 2012
Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
WAGNER HOLGER0 citations40